Published in Arch Intern Med on August 01, 1983
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol (1982) 5.44
Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis (1995) 2.36
Specific cellular immune unresponsiveness in human filariasis. Immunology (1977) 2.23
Human eosinophils express transforming growth factor alpha. J Exp Med (1990) 2.04
The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01
Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med (1989) 1.97
Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci U S A (1983) 1.91
Bronchoconstrictor effects of leukotriene C in humans. Science (1982) 1.91
Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest (2000) 1.85
Nosocomial Legionnaires' disease caused by aerosolized tap water from respiratory devices. J Infect Dis (1982) 1.81
Isolation and characterization of a seventh serogroup of Legionella pneumophila. J Clin Microbiol (1983) 1.66
Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol (1993) 1.65
Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis (1978) 1.65
Eosinophilia. J Allergy Clin Immunol (1984) 1.65
Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am (1993) 1.63
Brucellosis in a group of travelers to Spain. JAMA (1984) 1.63
Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci U S A (1989) 1.62
CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med (1991) 1.58
IL-4 directly modulates function of a model human intestinal epithelium. J Immunol (1994) 1.53
Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem (1989) 1.49
Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol (1997) 1.45
Performance measurement in pneumonia care: beyond report cards. Mayo Clin Proc (1998) 1.45
Detection of soluble Legionella pneumophila antigens in serum and urine specimens by enzyme-linked immunosorbent assay with monoclonal and polyclonal antibodies. J Clin Microbiol (1984) 1.40
The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs). J Immunol (1980) 1.36
Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. J Biol Chem (1992) 1.35
Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils. J Immunol (2001) 1.33
Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. J Exp Med (1997) 1.32
Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells. Blood (2000) 1.31
Release of C8 binding protein (C8bp) from the cell membrane by phosphatidylinositol-specific phospholipase C. Blood (1988) 1.30
Co-compartmentalization of MAP kinases and cytosolic phospholipase A2 at cytoplasmic arachidonate-rich lipid bodies. Am J Pathol (1998) 1.30
Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Proc Natl Acad Sci U S A (1980) 1.30
Pumonary aspergillosis during hospital renovation. Am Rev Respir Dis (1978) 1.28
Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy (2008) 1.26
Human eosinophils express functional interleukin 2 receptors. J Clin Invest (1991) 1.26
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin. Proc Natl Acad Sci U S A (1996) 1.26
The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. Am Rev Respir Dis (1993) 1.25
Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. Blood (1991) 1.24
Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation (1997) 1.23
Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest (1993) 1.23
Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. J Biol Chem (2001) 1.21
Antiparasitic drugs. N Engl J Med (1996) 1.20
Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol (1996) 1.20
Endemic filariasis on a Pacific Island. II. Immunologic aspects: immunoglobulin, complement, and specific antifilarial IgG, IgM, and IgE antibodies. Am J Trop Med Hyg (1982) 1.19
False-positive blood cultures. Association with nonsterile blood collection tubes. JAMA (1976) 1.18
Phosphatidylinositol-specific phospholipase C, a possible virulence factor of Staphylococcus aureus. J Clin Microbiol (1989) 1.17
Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120. J Exp Med (1989) 1.16
Familial predisposition to filarial infection--not linked to HLA-A or-B locus specificities. Acta Trop (1981) 1.15
Prevalence and significance of Legionella pneumophila contamination of residential hot-tap water systems. J Infect Dis (1985) 1.14
The regulatory and effector roles of eosinophils. Adv Immunol (1979) 1.14
Ultrastructural immunogold localization of tumor necrosis factor-alpha to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome. J Histochem Cytochem (1993) 1.14
Bancroftian filariasis and ivermectin. N Engl J Med (1990) 1.11
Fluorescent staining for leukocyte chemotaxis. Eosinophil-specific fluorescence with aniline blue. J Immunol Methods (1988) 1.11
Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J Histochem Cytochem (1992) 1.10
IL-4-dependent regulation of TGF-alpha and TGF-beta1 expression in human eosinophils. J Immunol (1998) 1.10
IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J Immunol (1996) 1.10
Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and 3T3 fibroblasts. Int Arch Allergy Immunol (1994) 1.09
The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA (1997) 1.09
CD40 expression by human peripheral blood eosinophils. J Clin Invest (1996) 1.07
Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. J Exp Med (1996) 1.07
The human eosinophil: roles in host defense and tissue injury. Am J Pathol (1980) 1.07
'Golden tongue' syndrome caused by Ramichloridium schulzeri. Arch Dermatol (1985) 1.06
Arachidonic acid incorporation by cytoplasmic lipid bodies of human eosinophils. Blood (1985) 1.06
EliCell: a gel-phase dual antibody capture and detection assay to measure cytokine release from eosinophils. J Immunol Methods (2000) 1.06
An outbreak of gram-negative bacteremia traced to contaminated O-rings in reprocessed dialyzers. Ann Intern Med (1993) 1.05
Malassezia furfur catheter infection cured with antibiotic lock therapy. Am J Med (1991) 1.05
Ultrastructural immunogold localization of subcellular sites of TNF-alpha in colonic Crohn's disease. J Leukoc Biol (1995) 1.04
Fever and headache in a splenectomized woman. Rev Infect Dis (1989) 1.02
The spectrum of Bacillus bacteremias in heroin addicts. Arch Intern Med (1979) 1.02
Eosinophil ablation and tumor development. Oral Oncol (1999) 1.02
Eotaxins. Contributing to the diversity of eosinophil recruitment and activation. Am J Respir Cell Mol Biol (2001) 1.02
Early detection of hypersensitivity pneumonitis in office workers. Am J Med (1978) 1.02
Release of prostaglandin E2 by microfilariae of Wuchereria bancrofti and Brugia malayi. Am J Trop Med Hyg (1992) 1.01
Intravascular filarial parasites elaborate cyclooxygenase-derived eicosanoids. J Exp Med (1990) 1.01
Outbreak of JK diphtheroid infections associated with environmental contamination. J Clin Microbiol (1984) 1.01
Perirectal abscess caused by Legionella pneumophila and mixed anaerobic bacteria. Ann Intern Med (1983) 1.00
Airway eosinophils and lymphocytes in asthma. Birds of a feather? Am Rev Respir Dis (1992) 0.99
Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis (1991) 0.99
Lack of TGF-alpha and TGF-beta 1 synthesis by human eosinophils in chronic oral ulcers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 0.99
Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome. Lab Invest (1990) 0.99
Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific. Am J Trop Med Hyg (2001) 0.97
Production of transforming growth factor alpha by hamster eosinophils. Am J Pathol (1990) 0.96
Cell-mediated immunity in experimental filariasis: lymphocyte reactivity to filarial stage-specific antigens and to B- and T-cell mitogens during acute and chronic infection. Cell Immunol (1978) 0.96
The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Chest (1999) 0.96
Arachidonic acid metabolism in filarial parasites. Exp Parasitol (1990) 0.95
Iodopyracet transport by isolated perfused flounder proximal renal tubules. Am J Physiol (1969) 0.95
Imported Fasciola hepatica infection in the United States and treatment with triclabendazole. Clin Infect Dis (2001) 0.94
Incorporation of arachidonic acid by microfilariae of Brugia malayi. J Infect Dis (1985) 0.94
Pseudomonas fluorescens bacteremia from blood transfusion. Am J Med (1984) 0.94
Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis. J Immunol (1981) 0.94
Tourism-acquired Mansonella ozzardi microfilaremia in a regular blood donor. JAMA (1978) 0.93
Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). J Biol Chem (1984) 0.92
Cefepime versus ceftazidime as empiric therapy for fever in neutropenic patients with cancer. Ann Pharmacother (2000) 0.91
Heterogeneity of leukotriene C4 production by eosinophils from asthmatic and from normal subjects. Am Rev Respir Dis (1988) 0.91
Depletion of eosinophil infiltration by anti-IL-5 monoclonal antibody (TRFK-5) accelerates open skin wound epithelial closure. Am J Pathol (1997) 0.90
Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. J Leukoc Biol (1998) 0.90
Epidemic measles in Chicago in 1983. Sustained transmission in the preschool population. Am J Dis Child (1986) 0.89
Ultrastructural localization of prostaglandin endoperoxide synthase (cyclooxygenase) to isolated, purified fractions of guinea pig peritoneal macrophage and line 10 hepatocarcinoma cell lipid bodies. Int Arch Allergy Immunol (1993) 0.88
Intravascular filarial parasites inhibit platelet aggregation. Role of parasite-derived prostanoids. J Clin Invest (1992) 0.88
Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol (1994) 0.88